Serum concentrations of CXCL11, reported to be raised in early SSc patients when compared with healthy individuals, strongly associated with disease activity [190], while pro-angiogenic CXCL16 was elevated in SSc, particularly in patients with PAH [189,190]. This evidence concerns the gene CXCL11 and systemic sclerosis.